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a b s t r a c t
Introduction: Pericardiocentesis is an invasive procedure for treatment of large pericardial
effusion or cardiac tamponade and for diagnostics of pericardial effusion of unknown
origin. Fluoroscopy navigation has been the preferred method during the past
decades. Nevertheless, new imaging methods such as echocardiography emerged as
an alternative guiding method for pericardiocentesis. These methods may improve safety
of the procedure.
Methods: All consecutive pericardiocenteses performed in noninvasive cardiology depart-
ment of a tertiary cardiovascular center during the period between 1998 and 2012
were prospectively recorded. We focused on the procedural safety and procedural success
rate.
Results: During a 15-year period, 253 pericardiocenteses were performed in 185 patients.
Most of the procedures (240 cases) were performed under echocardiographic control in our
noninvasive cardiology laboratory under strictly sterile conditions and with equipment for
cardiopulmonary resuscitation on site. Etiology of effusion was heart transplantation in
38 patients (25%), postoperative in 20 patients (14%), infective pericarditis in 25 patients
(16%), malignancy in 18 patients (12%), and invasive procedures in 19 patients (8%). Apical
approach was the most frequent in 218 patients (92%), parasternal in 13 patients (5%) and
subxiphoideal in 7 patients (3%). The procedural success rate was 97% overall, with a total
complication rate of 3% (2 major complications (0.3%); 7 minor complications (2.7%)).
Minor complications included 2 cases of small pneumothorax, 2 cases of pericardial ﬂuid
drainage into pleural space, 2 cases of transient right chamber entries, and in 1 case the
procedure was complicated by hemopericardium without the need for surgical manage-
ment. Major complications included 2 cases due to ventricular perforation, one with left
ventricule wall laceration in a loculated effusion and one complication due to right
ventricular laceration, both resulting in hemopericardium and requiring emergency sur-
gical repair.
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Conclusion: Echocardiography-guided pericardiocentesis  performed by echocardiologists in
noninvasive cardiology department under strictly sterile conditions and with equipment for
cardiopulmonary resuscitation is a safe procedure with infrequent complications. Apical
entry site is safe and the dominant approach for pericardiocentesis under echocardiographic
navigation.
# 2015 The Czech Society of Cardiology. Published by Elsevier Sp. z o.o. All rights reserved.
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.Introduction
Pericardial effusion is deﬁned as a presence of abnormal
accumulation of ﬂuid in the pericardial cavity either as an
incidental ﬁnding or a manifestation of cardiac as well as
systemic disease. Cardiac tamponade is a clinical syndrome
resulting from increase of pericardial pressure, and chamber
compression leading to hemodynamic compromise [1]. The
clinical presentation of pericardial effusion depends on the
speed of pericardial ﬂuid accumulation and pericardial
compliance. In slowly accumulated pericardial ﬂuid, as in
chronic cardiac or systemic disease, the pericardium stretches
allowing accumulation of signiﬁcant amount of pericardial
ﬂuid, till 1.5–2 L, without the manifestation of cardiac
tamponade [2–4]. Pericardial tamponade is a life-threatening
medical emergency with serous hemodynamic impact includ-
ing shock, and death, which requires urgent management.
Pericardiocentesis is an invasive procedure for treatment of
large pericardial effusion or cardiac tamponade and for
diagnostic purposes. Blind pericardial aspiration via a sub-
xiphoid approach is advisable only as an emergency procedure
as it may be associated by high complication rate with
recorded mortality and morbidity rates of 6% [5,6]. Fluoroscopy
navigation has been the preferred method during the past
decades. Currently, 2-dimensional echo-guided pericardio-
centesis appears to be an alternative technique for guidance of
pericardiocentesis [6–10].
Methods
We evaluated our single center experience with echocardio-
graphically guided pericardiocentesis performed in noninva-
sive cardiology department. All pericardiocenteses guided by
2-dimensional echocardiography performed in our noninva-
sive cardiology department were prospectively recorded in the
period between 1998 and 2012. The main focus was on efﬁcacy
and safety of the procedure with evaluation of procedural
complications.
Echocardiographic evaluation
All pericardiocenteses were performed by 15 participating
echocardiologists under strictly sterile conditions and with
equipment for cardiopulmonary resuscitation on site. All
procedures were guided by echocardiography; no ﬂuoroscopy
for navigation was used. Standard 2-dimensional echocardio-
graphic images with commercially available equipment wereobtained (Image point – Hewlett Packard, Accuson Soquoia
512, Vivid i, Vivid 5, Vivid 7 – General Electric). Right atrial
systolic collapse (>1/3 of systole duration), diastolic chamber
compression or collapse of right ventricle, inferior vena cava
plethora (inspiratory decrease of diameter by <50%) [11], and
respiratory variation of mitral and tricuspid inﬂow velocities
were used to evaluate the hemodynamic impact of pericardial
effusion [11–16]. Mitral and tricuspid valve velocities were
obtained by using PW Doppler ultrasound by placing the
sample volume on the tip of the leaﬂets to record antegrade
ﬂow. The cut-off value of >25% was considered as sign of
hemodynamically signiﬁcant pericardial effusion [15].
Pericardiocentesis
The location, distribution, and the ideal entry site were
determined ﬁrst by echocardiography [17]. After local inﬁltra-
tion with lidocaine, a needle (16–18 gauge) was introduced and
by reaching the pericardial ﬂuid a guidewire was inserted into
the pericardium. After dilation of the puncture site with a
dilator, the catheter was then inserted and the guidewire
withdrawn. Drainage was performed by large volume syringe
until the pericardial sac was nearly emptied. In some patients
the pericardial catheter was left for complete drainage and was
removed once the amount of ﬂuid drained was <30 ml/24 h
and follow-up echocardiography showed no signiﬁcant resid-
ual effusion. Pericardiocentesis was considered successful if
the pericardial ﬂuid was drained with relief of symptoms of
tamponade. Minor complication is an event requiring
noninvasive monitoring only. Major complication is consid-
ered as an undesirable event occurring as a result of
pericardiocentesis that required invasive intervention such
as need for emergency surgery or pleural drainage. Procedural
complications were evaluated till hospital discharge. Patients
on anticoagulation therapy on admission with hemodynamic
stability were managed after the decrease of INR <2.
Deﬁnitions
Large pericardial effusion was deﬁned as echocardiographi-
cally free space of >10 mm [18]. Recurrence was deﬁned as any
accumulation of ﬂuid within 21 days requiring repetition of
pericardiocentesis. Large symptomatic effusions including
those with hemodynamic collapse were considered as clinically
signiﬁcant; effusions with hemodynamic collapse were accom-
panied by hypotension (<90 mmHg) and/or requiring vasopres-
sors. Emergent pericardiocentesis was a procedure performed
in patients with hemodynamic collapse immediately after
echocardiographic diagnosis in the emergency department,
Table 1 – Patient characteristics, etiology, and hemody-
namic status.
Characteristics of patients
Total number of patients 185
Mean age  SD (years) 56  15
Male, no. (%) 170 (67%)
Female, no. (%) 83 (32%)
Total number of procedures 253
Etiology of pericardial effusion, no. (%)
Malignancy 21 (13%)
Postoperative 31 (20%)
Pericarditis 33 (21%)
Heart transplantation 44 (28%)
Invasive procedures 18 (11%)
Others 10 (6%)
Hemodynamic status, no. (%)
Echocardiographic signs of tamponade 102 (46%)
Without clinical and echocardiographic
signs of tamponade
109 (50%)
Clinical tamponade 59 (28%)
Hemodynamic collapse 30 (13%)
Antithrombotic therapy, no. (%)
Anticoagulation 28 (11%)
Acetylsalicylic acid 97 (38%)
Dual antiplatelet therapy 2 (1%)
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diagnosis of symptomatic effusion and performing blood tests.
Statistical analysis
Descriptive results were reported as mean  standard deviation
(SD), median with range or as frequency percentages. Statistical
analysis was performed by program Statistica version 10.
Results
During a 15-year period, 253 pericardiocenteses were per-
formed in 185 patients, 83 (32%) female and 170 (67%) male
patients, with a mean age of 55  14.9 years. The main
symptoms of patients were malaise and exertional dyspnea in
82%, hypotension in 30 patients (13%), and tachycardia in
60 patients (26%).
In our cohort the etiology of effusion accounted for previous
heart transplantation in 44 patients (28%), malignancy in
21 patients (13%) mostly due to bronchogenic cancer (11 cases)
and in sporadic cases due to lymphoma, gastric cancer, renal
adenocarcinoma and breast cancer. Postoperative etiology
was in 31 patients (14%), previous invasive procedure
(after pacemaker implantations and electrode perforations
in 8 cases, after endomyocardial biopsy in 2 cases and due
to perforated coronary sinus in 1 case during right
heart catheterization) in 18 patients (8%), pericarditis in
33 patients (11%), and chronic renal disease in 10 patients
(6%); in 28 patients the etiology was unspeciﬁed (Graph 1).
The effusion was large (echocardiographically deﬁned as
>10 mm echo free space) in 213 cases (86%), from which
195 cases (92%) had circumferential distribution, and loculated
distribution in 4 cases (1%). The mean volume of effusion was
842  504 ml. Color of the effusions was bloody in 130 cases
(53%), serosanguineous in 28 cases (12%), and serous in
94 cases (36%).
The apical entry site was the most frequent in 218 patients
(92%), parasternal in 13 patients (5%), subxiphoideal in
7 patients (3%) and in 15 patients (6%) the entry site was
unspeciﬁed (Table 2).
There were 28 patients (11%) on anticoagulation therapy on
admission, 97 patients (38%) with acetylsalicylic acid, and
2 patients on dual antiaggregation therapy.0%
5%
10%
15%
20%
25%
30%
35%
Malignancy Postop era ve Per icar dis Hear t
transplantaon
Invasive
proced ures
Graph 1 – Etiology of pericardial effusion.In our study the echocardiographic tamponade was
reported in 102 patients (46%), clinical tamponade in
59 patients (25%), and hemodynamic collapse accounting for
in 30 patients (13%). There were 109 patients (50%) with large
pericardial effusion without clinical and echocardiographic
signs of tamponade (Table 1). The sensitivity of echocardiog-
raphy for clinical tamponade was 77% with a speciﬁcity of 65%.
The negative predictive value was 89% with a positive
predictive value around 45%.
We report 62 patients (33%) who required further pericar-
diocentesis during 21 days of follow-up. According to the
etiology of effusion, 24 patients (38%) had a recent history of
heart transplantation, 14 patients (22%) underwent cardiac
surgery recently, malignancy was documented in 6 patients
(9%), 21 patients (33%) were diagnosed with pericarditis, and in
6 patients (9%) the etiology was not documented.Table 2 – Echocardiographic characteristics of pericardial
effusion and entry sites.
Distribution of effusion, no. (%)
Circumferential 195 (92%)
Loculated 4 (0.5%)
Not speciﬁed 36 (14%)
Volume of effusion (mean W SD) 842  504 ml
Appearance of effusion, no. (%)
Bloody 130 (53%)
Serosanguineous 28 (12%)
Serous 94 (36%)
Entry site, no. (%)
Para-apical 218 (92%)
Parasternal 13 (5%)
Subxiphoideal 7 (3%)
Unspeciﬁed 15 (6%)
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due to the recurrence of large pericardial effusion requiring
repeated pericardiocentesis.
In our study the procedural success rate was 97% overall,
with a total complication rate of 3% (2 major complications
(0.3%); 7 minor complications (2.7%)). Minor complications
included 2 cases of small pneumothorax, 2 cases of pericardial
ﬂuid drainage into pleural space, transient right chamber
entries in 2 patients, and in 1 patient the procedure was
complicated by hemopericardium due to anticoagulation
therapy without the need for surgical management. Major
complications included 2 cases due to ventricular perforation,
one with left ventricule wall laceration in a loculated effusion
and one complication due to right ventricular perforation, both
resulting in hemopericardium and requiring emergency
surgical repair.
Discussion
Cardiac tamponade is curable, but when unrecognized it might
result in cardiogenic shock with high risk of mortality [19]. The
predominant clinical signs of patients in our cohort who
presented with tamponade were exertional dyspnea 89% and
tachycardia 26%.
Large effusions, deﬁned as echocardiographically
>10 mm, accounted for 86%, mostly with circumferential
distribution 92%. Echo-guided pericardiocentesis can be
performed by subxiphoid and chest wall approaches. In the
present study, the apical approach was preferred in most
patients due to dominant circumferential distribution of
the effusion.
Concerning the etiology, pericardial effusion due to heart
transplantation, pericarditis and postoperative were the
leading causes accounting for 28%, 21% and 20% respectively.
Moderate to large effusions in the setting of orthotopic heart
transplantation have been reported in earlier studies in about
20% of patients within the ﬁrst 3 months [20,21], however the
majority usually resolve within 3 months [22]. In our cohort,
pericardial effusion after heart transplantation was diagnosed
during echocardiography follow-up during hospitalization.
The average time between transplantation and pericardio-
centesis was 42 days. Potential mechanisms of pericardial
effusion in the early phase are autoimmune reaction or
postpericardiotomy syndrome; lately pericardial perfusion is
usually due to transplant rejection. Pericardiocentesis was
performed only when these effusions were symptomatic with
tendency for progression to larger sizes (>15 mm).
In patients on anticoagulation therapy and without signs of
hemodynamic compromise, the intervention was postponed
until the INR decreased (INR <2). In 4 patients with INR 2–3, the
procedure was performed due to hemodynamic collapse
without further complications.
The mere presence of pericardial effusion does not deﬁne
clinical tamponade. Echocardiography is a sensitive and
available diagnostic tool for detecting pericardial effusion
and determining ﬁndings suggestive for tamponade physiolo-
gy [11,13–16,23,24].
We reported 102 patients (46%) with echocardiographic
tamponade and 59 patients (25%) with clinical tamponade, andhemodynamic collapse accounting for in 30 patients (13%).
Cardiac tamponade is a continuum of hemodynamic effects;
the echocardiographic ﬁndings in our cohort are sensitive with
lower speciﬁcity, which may overdiagnose cardiac tamponade
in patients with slight evidence of hemodynamic compromise
[24–26].
All pericardiocenteses performed were successful for
relieving tamponade in most patients with a success rate of
97% and a total complication rate of 3% (minor 2.7%, major 0.3%).
Minor complications included small pneumothorax noted
on radiographs in 2 patients which resolved spontaneously.
Perforation of the pleura with partial drainage of the
pericardial ﬂuid into the pleural cavity was detected in
2 cases and was managed by repeated pericardiocentesis,
which was successful. Transient right chamber laceration was
in 2 patients without signiﬁcant progression of pericardial
effusion and the need for invasive treatment. One patient
developed hemopericardium due to anticoagulation therapy
applied after the procedure and was managed by further
aspiration from the pericardial catheter.
Concerning major complications, 1 case with a loculated
effusion on anterolateral left ventricular wall with signs of
organization results in worsening of pericardial effusion due to
transient chamber entry and the second case was nonfatal
complication due to right ventricle perforation resulting in
hemopericardium, both cases required surgical management.
Both patients survived without further complications or
recurrence of effusion. No death occurred as a result of
pericardiocentesis.
These results in our cohort regarding safety of echo-guided
pericardiocentesis are consistent with the ﬁndings of other
investigators [10]. Using these inclusion criteria, this study is
unique by providing clear evidence of the safety of the
procedure performed in noninvasive cardiology department
with equipment of cardiopulmonary resuscitation on board
and without ﬂuoroscopy.
Limitations
The main limitation of our prospective registry is the absence
of a control group which is the reason we can not calculate the
sensitivity and speciﬁcity of various echocardiographic signs
of tamponade. The strength of this evaluation is by utilizing
the data from our prospective registry of consecutive echo-
guided pericardiocenteses with around 95% follow-up till
hospital discharge.
Conclusion
Echo-guided pericardiocentesis, performed in noninvasive
cardiology department, under strictly sterile conditions and
with equipment for cardiopulmonary resuscitation on board,
is a safe procedure with infrequent complications. Apical entry
is safe and the dominant approach for pericardiocentesis
under echocardiographic navigation [10,19]. Echocardiography
is a sensitive and available diagnostic tool for detecting
pericardial effusion and determining its hemodynamic
impact. Increased safety and markedly lower cost compared
c o r e t v a s a 5 7 ( 2 0 1 5 ) e 2 3 9 – e 2 4 4 e243with surgery ensure that echo-guided pericardiocentesis is a
procedure of choice.
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